Multiple myeloma and other plasma cell disorders

Shaji Kumar MD and Sagar Lonial MD review data from key studies in multiple myeloma and other plasma cell disorders presented at the 2015 American Society of Hematology Annual Meeting.

Share

Program Content

Activities

  • ELOQUENT-2: Elotuzumab + Rd in R/R MM
    ELOQUENT-2: Elotuzumab + Len/Dex in R/R MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 07, 2015

    Expires: December 05, 2016

  • VRd vs RD Induction in MM
    SWOG S0777: VRd Vs Rd in Previously Untreated MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 07, 2015

    Expires: December 05, 2016

  • Bortezomib in NDMM
    HOVON-65/GMMG-HD4: Long-term Results for Bortezomib-Based Therapy in NDMM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 07, 2015

    Expires: December 05, 2016

  • Ixazomib in Untreated MM
    Ixazomib Plus Cyclo/Dex in Newly Diagnosed MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 08, 2015

    Expires: December 06, 2016

  • Weekly Carfilzomib in RR MM
    Phase I/II CHAMPION-1: Weekly Carfilzomib/Dexamethasone for Relapsed/Refractory Myeloma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2015

    Expires: December 07, 2016

  • IFM 2013-04: VTD vs VCD in MM
    IFM 2013-04: VTD vs VCD Before ASCT in Patients With MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2015

    Expires: December 07, 2016

  • KEYNOTE-023: Pembro + Len/Dex in R/R MM
    KEYNOTE-023: Pembrolizumab + Len/Dex in R/R MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 10, 2015

    Expires: December 08, 2016

  • Pembrolizumab + Pom/Dex in R/R MM
    Phase II Study: Pembrolizumab + Pomalidomide/Dexamethasone for Patients With R/R MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 11, 2015

    Expires: December 09, 2016

  • IMAJEM: PET/CT in MM
    IMAJEM, a Substudy of IFM 2009: Prognostic Role of MRI and PET/CT in MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 11, 2015

    Expires: December 09, 2016

  • Ixazomib + Len/Dex in R/R MM
    TOURMALINE-MM1: Improved PFS With Ixazomib + Len/Dex in R/R MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 11, 2015

    Expires: December 09, 2016

  • Predictive Value of MRD in MM
    Value of MRD to Predict PFS in MM: Results From IFM/DFCI 2009
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2015

    Expires: December 10, 2016

  • Daratumumab + Pom/Dex in RR MM
    Phase Ib MMY1001: Daratumumab Plus Pom/Dex in Patients With R/R MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2015

    Expires: December 10, 2016

  • Anti-BCMA CAR T Cells Effective in MM
    First-in-Human Trial: BCMA-Targeted CAR T Cells in Advanced R/R MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 16, 2015

    Expires: December 14, 2016

  • Downloadable Slideset
    Recent Updates in Multiple Myeloma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 19, 2016

    Expires: January 17, 2017

  • Carfilzomib ± Filanesib in R/R MM
    ARRAY-520-216: Phase II Trial of Carfilzomib With or Without Filanesib in R/R MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022
  • IFM 2009: RVD ± ASCT in Myeloma
    IFM 2009: RVD ± Autologous Transplantation in Younger Patients With Newly Diagnosed MM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen